Microglial changes occur without neural cell death in diabetic retinopathy

Area of Science:

• Ophthalmology
• Neuroscience
• Endocrinology

Background:

• Diabetic retinopathy (DR) involves early neuroglial changes preceding vascular alterations.
• Understanding the precise sequence of these early changes is crucial for timely intervention.

Purpose of the Study:

• To investigate the temporal sequence of neuroglial changes in the retina during early-stage experimental diabetic retinopathy.
• To assess the impact of insulin treatment on these early retinal changes.

Main Methods:

• Alloxan-induced diabetes in C57/Bl6 mice, with daily insulin injections.
• Weekly monitoring of body weight and blood glucose levels.
• Electroretinography and scanner laser ophthalmoscopy at 15 days, 1 month, and 3 months post-diabetes onset.
• Retinal histology assessed via TUNEL and immunocytochemistry for active caspase-3 and GFAP.

Main Results:

• Diabetes induction confirmed by hyperglycemia, weight loss, and increased glycated hemoglobin.
• Electroretinography showed decreased b/a wave amplitude ratio and delayed oscillatory potentials at 3 months.
• Retinal vasculature and fundus remained unchanged; no Müller glial reaction or apoptosis observed.
• Significant microglial morphological changes (dendrite shortening) were detected early.

Conclusions:

• Microglial activation is an early event in diabetic retinopathy progression, coinciding with initial electroretinographic alterations.
• Absence of apoptosis suggests insulin provides neuroprotection in this model.
• These findings highlight the role of microglia in early DR pathogenesis.